Edward O. Lanphier
Chairman at Gerostate Alpha, Inc.
Profile
Mr. Edward O.
Lanphier, II, is President, Chief Executive Officer & Director at Sangamo BioSciences, Inc., a Principal at Red Abbey Venture Partners LLC, and a Member at Biotechnology Industry Organization.
He is on the Board of Directors at Sangamo BioSciences, Inc. and The Biotechnology Institute.
Mr. Lanphier is the founder of Sangamo BioSciences, Inc. and has served as President, Chief Executive Officer and a member of the Board of Directors since the company’s inception in 1995.
Before founding Sangamo, from 1992 to 1997, he was associated with Somatix Therapy Corporation, a leading gene therapy company, in positions including EVP, Commercial Development and Chief Financial Officer.
Prior to Somatix, Mr. Lanphier was President and Chief Executive Officer of BioGrowth, Inc., a biotechnology company that merged with Celtrix Pharmaceuticals, Inc. in 1991.
From 1986 to 1987, he was VP of Corporate Development at Biotherapeutics, Inc., and served in the same capacity at Synergen, Inc. from 1984 to 1986.
Before joining Synergen, he was employed by Eli Lilly and Company in the strategic business planning-biotechnology group.
He is a director of the Biotechnology Industry Organization (BIO) and a member of its Emerging Companies Section.
He is also a member of the Board of Directors of Cengent Therapeutics, Inc. and Cell ExSys, and was recently appointed to the board of The Biotechnology Institute, a national nonprofit organization dedicated to education and research about the impact of biotechnology.
Mr. Lanphier holds a BA in biochemistry from Knox College.
Edward O. Lanphier active positions
| Companies | Position | Start |
|---|---|---|
Biotechnology Innovation Organization
 Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Corporate Officer/Principal | - |
The Biotechnology Institute
 The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Director/Board Member | - |
Gerostate Alpha, Inc.
 Gerostate Alpha, Inc. Miscellaneous Commercial ServicesCommercial Services Gerostate Alpha, Inc. develops pharmaceuticals for treating aging and age-related diseases. The company was founded by Simon Melov, Gordon Lithgow and Mark Lucanic in June 2018 and is headquartered in Novato, CA. | Chairman | 2019-04-30 |
Former positions of Edward O. Lanphier
| Companies | Position | End |
|---|---|---|
Red Abbey Venture Partners LLC
 Red Abbey Venture Partners LLC Investment ManagersFinance Red Abbey Venture Partners LLC (Red Abbey Venture Partners) is a venture capital firm subsidiary of Red Abbey LLC founded in 2004 by Philip Goelet, W. Matthew Zuga, and Frank Adair Bonsal. The firm is headquartered in Baltimore, Maryland. | Consultant / Advisor | 2022-12-22 |
| SANGAMO THERAPEUTICS, INC. | Chief Executive Officer | 2016-05-31 |
Somatix Therapy Corp.
 Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Director of Finance/CFO | 1997-04-30 |
Celtrix Pharmaceuticals, Inc.
 Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The private company is based in Santa Clara, CA. | Corporate Officer/Principal | 1992-12-30 |
Biotherapeutics, Inc.
 Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | 1986-12-31 |
Training of Edward O. Lanphier
| Knox College | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 2 |
|---|---|
| ELI LILLY AND COMPANY | Health Technology |
| SANGAMO THERAPEUTICS, INC. | Health Technology |
| Private companies | 11 |
|---|---|
Celtrix Pharmaceuticals, Inc.
Celtrix Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Part of Insmed, Inc., Celtrix Pharmaceuticals, Inc. researches and develops potential therapeutic products. The private company is based in Santa Clara, CA. | Health Technology |
Somatix Therapy Corp.
Somatix Therapy Corp. BiotechnologyHealth Technology Somatix Therapy Corp. researches, develops, and commercialize proprietary processes for the genetic modification of cells and their use in the treatment of human disease. Somatix's assets include its highly efficient gene transfer technology, broad-based intellectual property, and focused product development programs. The company's most advanced clinical development program, the GVAX cancer vaccine, is in Phase I/II clinical trials for the treatment of metastatic renal cell carcinoma, advanced melanoma, and prostate cancer. It is located in Alameda, CA | Health Technology |
| Synergen, Inc. | Utilities |
Biotechnology Innovation Organization
Biotechnology Innovation Organization Miscellaneous Commercial ServicesCommercial Services Biotechnology Innovation Organization is the world's biotechnology organization, providing advocacy, business development and communications services for more than 1,200 members worldwide. BIO members are involved in the research and development of innovative healthcare, agricultural, industrial and environmental biotechnology technologies. Corporate members range from entrepreneurial companies developing a first product to Fortune 100 multinationals. also represent state and regional biotech associations, service providers to the industry and academic centers. | Commercial Services |
Red Abbey Venture Partners LLC
Red Abbey Venture Partners LLC Investment ManagersFinance Red Abbey Venture Partners LLC (Red Abbey Venture Partners) is a venture capital firm subsidiary of Red Abbey LLC founded in 2004 by Philip Goelet, W. Matthew Zuga, and Frank Adair Bonsal. The firm is headquartered in Baltimore, Maryland. | Finance |
Buck Institute for Research on Aging
 Buck Institute for Research on Aging Miscellaneous Commercial ServicesCommercial Services Buck Institute for Research on Aging operates independent research institute for connection between aging and chronic disease. The company is headquartered in Novato, CA. | Commercial Services |
The Biotechnology Institute
The Biotechnology Institute Miscellaneous Commercial ServicesCommercial Services The Biotechnology Institute is a non-profit organization, which engages in designing and managing programs about biotechnology research. Its programs include BioGENEius Challenges, leadership awards, and Adopt-A-School. The company was founded in 1998 and is headquartered in Washington, DC. | Commercial Services |
| BioGrowth, Inc. | |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |
Alliance for Regenerative Medicine
 Alliance for Regenerative Medicine Medical/Nursing ServicesHealth Services ARM is a Washington, DC-based multi-stakeholder advocacy organization that promotes global initiatives necessary to facilitate access to life-giving advances in regenerative medicine. The organization promotes legislative, regulatory reimbursement, investment, technical, and other initiatives to accelerate the development of safe and effective regenerative medicine technologies. ARM also works to increase public understand- ing of the field and its potential to transform human healthcare. Prior to the formation of ARM in 2009, there was a need for more coordinated and cohesive advocacy representing the interests of the companies, research institutions, investors and patient groups that comprise the entire regenerative medicine community. Today ARM has more than 140 members and is the leading global advocacy organization in this field. | Health Services |
Gerostate Alpha, Inc.
Gerostate Alpha, Inc. Miscellaneous Commercial ServicesCommercial Services Gerostate Alpha, Inc. develops pharmaceuticals for treating aging and age-related diseases. The company was founded by Simon Melov, Gordon Lithgow and Mark Lucanic in June 2018 and is headquartered in Novato, CA. | Commercial Services |
- Stock Market
- Insiders
- Edward O. Lanphier